Minireviews
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 26, 2022; 10(30): 10867-10872
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.10867
Table 1 Aß system for four ketosis-prone diabetes subgroups based on the presence/absence of autoantibodies and ß cell function

A+: Anti-GAD65 and IA-2 antibodies present in serum
A-: Anti-GAD65 and IA-2 antibodies not present in serum
ß+: Fasting serum C-peptide concentration greater than or equal to 1 ng/mL (0.33 nmol/L) or a peak serum C-peptide response to glucagon greater than or equal to 1.5 ng/mL (0.5 nmol/L)A+ß+: Autoantibodies present, beta cell function presentA-ß+: Autoantibodies absent, beta cell function present
ß-: Fasting serum C-peptide concentration is less than 1 ng/mL (0.33 nmol/L) or a peak serum C-peptide response to glucagon less than 1.5 ng/mL (0.5 nmol/L)A+ß-: Autoantibodies present, beta cell function absentA-ß-: Autoantibodies absent, beta cell function absent